Socioeconomic inequalities in prevalence, awareness, treatment and control of hypertension: evidence from the PERSIAN cohort study.

Autor: Amini M; Behavioral Disease Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran., Moradinazar M; Behavioral Disease Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran., Rajati F; Department of Health Education and Promotion, Research Center for Environmental Determinants of Health, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran., Soofi M; Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran., Sepanlou SG; Digestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Poustchi H; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Eghtesad S; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Moosazadeh M; Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Harooni J; Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran., Aghazadeh-Attari J; Clinical Research Institute,Occupational Medicine Center, Social Determinants of Health Research Center, Urmia University of Medical Sciences, Urmia, Iran., Fallahi M; Department of Occupational Health Engineering, School of Public Health, Non Communicable Disease Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran., Fattahi MR; Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Ansari-Moghaddam A; Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran., Moradpour F; Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran., Nejatizadeh A; Molecular Medicine Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran., Shahmoradi M; Endocrinology and Metabolism Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran., Mansour-Ghanaei F; Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran., Ostadrahimi A; Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Ahmadi A; Modeling in Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran., Khaledifar A; Modeling in Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran., Saghi MH; Department of Occupational Health Engineering, School of Public Health, Non Communicable Disease Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran., Saki N; Hearing Research Center, Department of Otolaryngology, Head and Neck Surgery, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Mohebbi I; Clinical Research Institute,Occupational Medicine Center, Social Determinants of Health Research Center, Urmia University of Medical Sciences, Urmia, Iran., Homayounfar R; NonCommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran., Farjam M; NonCommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran., Nadimi AE; Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran., Kahnooji M; Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran., Pourfarzi F; Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran., Zamani B; Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran., Rezaianzadeh A; Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Johari MG; Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Mirzaei M; Yazd Cardiovascular Research Centre, Shahid Sadoughi University of Medical Sciences, Yazd, Iran., Dehghani A; Centre For Healthcare Data Modeling, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran., Motlagh SFZ; Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran., Rahimi Z; Hearing Research Center, Department of Biostatistics and Epidemiology, School of Public Health, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Malekzadeh R; Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Najafi F; Department of Epidemiology, School of Health, Research Center for Environmental Determinants of Health, Research Institute for Health, Kermanshah University of Medical Sciences, Kermanshah, Iran. farid_n32@yahoo.com.
Jazyk: angličtina
Zdroj: BMC public health [BMC Public Health] 2022 Jul 22; Vol. 22 (1), pp. 1401. Date of Electronic Publication: 2022 Jul 22.
DOI: 10.1186/s12889-022-13444-x
Abstrakt: Background: Elevated blood pressure is associated with cardiovascular disease, stroke and chronic kidney disease. In this study, we examined the socioeconomic inequality and its related factors in prevalence, Awareness, Treatment and Control (ATC) of hypertension (HTN) in Iran.
Method: The study used data from the recruitment phase of The Prospective Epidemiological Research Studies in IrAN (PERSIAN). A sample of 162,842 adults aged >  = 35 years was analyzed. HTN was defined according to the Joint National Committee)JNC-7(. socioeconomic inequality was measured using concentration index (Cn) and curve.
Results: The mean age of participants was 49.38(SD =  ± 9.14) years and 44.74% of the them were men. The prevalence of HTN in the total population was 22.3%(95% CI: 20.6%; 24.1%), and 18.8%(95% CI: 16.8%; 20.9%) and 25.2%(95% CI: 24.2%; 27.7%) in men and women, respectively. The percentage of awareness treatment and control among individuals with HTN were 77.5%(95% CI: 73.3%; 81.8%), 82.2%(95% CI: 70.2%; 81.6%) and 75.9%(95% CI: 70.2%; 81.6%), respectively. The Cn for prevalence of HTN was -0.084. Two factors, age (58.46%) and wealth (32.40%), contributed most to the socioeconomic inequality in the prevalence of HTN.
Conclusion: The prevalence of HTN was higher among low-SES individuals, who also showed higher levels of awareness. However, treatment and control of HTN were more concentrated among those who had higher levels of SES, indicating that people at a higher risk of adverse event related to HTN (the low SES individuals) are not benefiting from the advantage of treatment and control of HTN. Such a gap between diagnosis (prevalence) and control (treatment and control) of HTN needs to be addressed by public health policymakers.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje